
### [MONDO:0000995](http://purl.obolibrary.org/obo/MONDO_0000995)
**Label:** familial periodic paralysis

**Subclasses:** [MONDO:0013908](http://purl.obolibrary.org/obo/MONDO_0013908) (TTPP3), [MONDO:0013234](http://purl.obolibrary.org/obo/MONDO_0013234) (hypokalemic periodic paralysis, type 2), [MONDO:0008570](http://purl.obolibrary.org/obo/MONDO_0008570) (thyrotoxic periodic paralysis, susceptibility to, 1), [MONDO:0019201](http://purl.obolibrary.org/obo/MONDO_0019201) (thyrotoxic periodic paralysis), [MONDO:0008223](http://purl.obolibrary.org/obo/MONDO_0008223) (hypokalemic periodic paralysis), [MONDO:0008224](http://purl.obolibrary.org/obo/MONDO_0008224) (hyperkalemic periodic paralysis), [MONDO:0013193](http://purl.obolibrary.org/obo/MONDO_0013193) (thyrotoxic periodic paralysis, susceptibility to, 2), 

**Corr. equiv. classes:** [Orphanet:682](http://www.orpha.net/ORDO/Orphanet_682), [OMIM:613345](http://purl.obolibrary.org/obo/OMIM_613345), [Orphanet:681](http://www.orpha.net/ORDO/Orphanet_681), [OMIM:613239](http://purl.obolibrary.org/obo/OMIM_613239), [OMIM:614834](http://purl.obolibrary.org/obo/OMIM_614834), [OMIM:188580](http://purl.obolibrary.org/obo/OMIM_188580), [Orphanet:79102](http://www.orpha.net/ORDO/Orphanet_79102), [OMIM:170400](http://purl.obolibrary.org/obo/OMIM_170400), [OMIM:170500](http://purl.obolibrary.org/obo/OMIM_170500), 

**Class expressions from DL-Learner:**

- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) 83.33%
- [HP:0003768](http://purl.obolibrary.org/obo/HP_0003768) (Periodic paralysis) and [HP:0010547](http://purl.obolibrary.org/obo/HP_0010547) (Muscle flaccidity) 83.33%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 83.33%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 83.33%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0003768](http://purl.obolibrary.org/obo/HP_0003768) (Periodic paralysis) 83.33%
- [HP:0003470](http://purl.obolibrary.org/obo/HP_0003470) (Paralysis) and [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) 83.33%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) 83.33%
- [HP:0003470](http://purl.obolibrary.org/obo/HP_0003470) (Paralysis) and [HP:0010547](http://purl.obolibrary.org/obo/HP_0010547) (Muscle flaccidity) 79.62%
- [HP:0010547](http://purl.obolibrary.org/obo/HP_0010547) (Muscle flaccidity) and [HP:0011042](http://purl.obolibrary.org/obo/HP_0011042) (Abnormality of potassium homeostasis) 77.78%
- [HP:0010547](http://purl.obolibrary.org/obo/HP_0010547) (Muscle flaccidity) and [HP:0010930](http://purl.obolibrary.org/obo/HP_0010930) (Abnormality of monovalent inorganic cation homeostasis) 77.78%
- [HP:0010547](http://purl.obolibrary.org/obo/HP_0010547) (Muscle flaccidity) and [HP:0010929](http://purl.obolibrary.org/obo/HP_0010929) (Abnormality of cation homeostasis) 77.78%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 77.78%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0011042](http://purl.obolibrary.org/obo/HP_0011042) (Abnormality of potassium homeostasis) 77.78%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0010930](http://purl.obolibrary.org/obo/HP_0010930) (Abnormality of monovalent inorganic cation homeostasis) 77.78%
- [HP:0003752](http://purl.obolibrary.org/obo/HP_0003752) (Episodic flaccid weakness) and [HP:0010929](http://purl.obolibrary.org/obo/HP_0010929) (Abnormality of cation homeostasis) 77.78%


